Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer

Friday, October 16, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals has announced the appointment of Tammi Gaskins as the new Chief Executive Officer, effective January 1, 2027. Gaskins, who currently serves as the Chief Commercial Officer, will succeed Tom McCourt, who is set to retire. This leadership transition aims to ensure continuity within the company.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tammi Gaskins appointed as new CEO, indicating leadership continuity.
  • Transition planned for January 1, 2027, allowing for a smooth handover.
  • Gaskins has experience as Chief Commercial Officer, suggesting readiness for the role.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
Apraglutide
Phase 1 · Chronic Kidney Disease

Full Press Release Details

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced that its Board of Directors appointed Chief Commercial Officer Tammi Gaskins as Chief Executive Officer and a member of the Board of Directors, effective January 1, 2027. On that date Chief Executive Officer Tom McCourt will retire from his current role and will remai

Frequently Asked Questions

Who has been appointed as the new CEO of Ironwood Pharmaceuticals?

Tammi Gaskins has been appointed as the new CEO of Ironwood Pharmaceuticals.

When will Tammi Gaskins officially become CEO?

Tammi Gaskins will officially become CEO on January 1, 2027.

Who is Tammi Gaskins replacing as CEO?

Tammi Gaskins is replacing Tom McCourt as CEO.

What position did Tammi Gaskins hold before becoming CEO?

Before becoming CEO, Tammi Gaskins was the Chief Commercial Officer.

ShareAdd on Google
Tags: IRWD Ironwood Pharmaceuticals Tammi Gaskins CEO appointment Tom McCourt biotechnology
Last updated: Oct 16, 2026

Biotech snapshot

Cash runway
$79M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ApraglutidePhase 1
Chronic Kidney Disease →

Catalyst track record

+57%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →